Aggregating multiple test results to improve medical decision-making

Abstract

Gathering observational data for medical decision-making often involves uncertainties arising from both type I (false positive)and type II (false negative) errors. In this work, we develop a statistical model to study how medical decision-making can be improved by repeating diagnostic and screening tests, and aggregating their results. This approach is relevant not only in clinical settings, such as medical imaging, but also in public health, as highlighted by the need for rapid, cost-effective testing methods during the SARS-CoV-2pandemic. Our model enables the development of testing protocols with an arbitrary number of tests, which can be customized to meet requirements for type I and type II errors. This allows us to adjust sensitivity and specificity according to application-specific needs. Additionally, we derive generalized Rogan--Gladen estimates for estimating disease prevalence, accounting for an arbitrary number of tests with potentially different type I and type II errors. We also provide the corresponding uncertainty quantification.

24 pages, 6 figures, 2 tables

References in corpus (6)

• Using excess deaths and testing statistics to improve estimates of COVID-19 mortalities
• Why case fatality ratios can be misleading: individual- and population-based mortality estimates and factors influencing them
• Epidemic Management and Control Through Risk-Dependent Individual Contact Interventions
• Modeling in higher dimensions to improve diagnostic testing accuracy: theory and examples for multiplex saliva-based SARS-CoV-2 antibody assays
• Tradeoffs in Hierarchical Voting Systems
• Optimal classification and generalized prevalence estimates for diagnostic settings with more than two classes